SIRT5 supports the anaplerotic entry of glutamine into the tricarboxylic-acid (TCA) cycle in malignant phenotypes of colorectal cancer (CRC) via activating glutamate dehydrogenase 1 (GLUD1) [28]. The gene discussed is GLUD1; the disease is colorectal cancer.